Clinical research - Press Releases

Date	Title	Company
28-Jul-2020	MSF: COVID-19 test maker Cepheid overcharging the world’s poorest countries	MSF UK
28-Jul-2020	Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer	AstraZeneca
24-Jul-2020	Idorsia announces financial results for the first half 2020	Idorsia Ltd
24-Jul-2020	Abcam plc Full Year Trading Update	Abcam plc
24-Jul-2020	Evelo Biosciences to Report Second Quarter 2020 Financial Results on Thursday, July 30, 2020	Evelo Biosciences
24-Jul-2020	The Ecodyst EcoChyll X7 Single Sample Rotary Vacuum Evaporator distributed by SP Genevac For a high-resolution image please contact sarahp@alto-marketing.com	Ecodyst, Inc
24-Jul-2020	Chi-Med Initiates a Phase I Trial of IDH1/2 Dual Inhibitor in Patients with Hematological Malignancies in China	Hutchison China MediTech Limited
24-Jul-2020	Bimekizumab Superior to Cosentyx® in Achieving Complete Psoriasis Skin Clearance	UCB
23-Jul-2020	QUAY EXPERTISE SUPPORTS NEW DRUG FOR TACTIC-E COVID-19 TRIAL	Quay Pharma
23-Jul-2020	HIGHLY-ACCURATE URINE TEST WHICH RULES OUT BLADDER CANCER BEING OFFERED FREE TO NHS TO HELP CLEAR COVID-19 BACKLOG	Arquer Diagnostics
22-Jul-2020	Q BIOMED TO SCALE UP PRODUCTION OF UTTROSIDE-B, A NOVEL CHEMOTHERAPEUTIC FOR LIVER CANCER, IN PREPARATION FOR IND FILING	About Q BioMed Inc.
22-Jul-2020	UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm	UCL Business
20-Jul-2020	Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease	Sanifit
17-Jul-2020	Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription	Verona Pharma plc
17-Jul-2020	Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020	Genmab
15-Jul-2020	NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis	NMD Pharma
15-Jul-2020	Lung cancer in non-smokers likely to respond differently to treatment	The Institute of Cancer Research
15-Jul-2020	EIT Health Wild Card winner attracts 1 million USD investment from Microsoft M12 and Mayfield	EIT Health
15-Jul-2020	OpSec Provides a COVID-19 Authenticity & Traceability Solution for Testing Kits and Pharmaceutical Products	OpSec Security
15-Jul-2020	Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU	Novartis